4
Changes in Ownership
HCW Biologics Inc. Filed Acc 0001209191-21-048063
Chief Executive Officer bought 627,500 shares at $8.00 ($5,020,000)
- Chief Executive Officer acquired 10,342,404 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Wong Hing C Chief Executive Officer | 2021-07-22 | Conversion | +6,316,691 | 10,602,405 | D | ||
| Wong Hing C Chief Executive Officer | 2021-07-22 | Conversion | +2,954,285 | 13,556,690 | D | ||
| Wong Hing C Chief Executive Officer | 2021-07-22 | Conversion | +1,071,428 | 14,628,118 | D | ||
| Wong Hing C Chief Executive Officer | 2021-07-22 | Purchase | +627,500 | $8.00 | $5,020,000 | 15,255,618 | D |
| Derivatives | |||||||
| Wong Hing C Chief Executive Officer | 2021-07-22 | Conversion · Series A Redeemable Preferred Stock | −6,316,691 | 0 | D | ||
| Wong Hing C Chief Executive Officer | 2021-07-22 | Conversion · Series B Redeemable Preferred Stock | −2,954,285 | 0 | D | ||
| Wong Hing C Chief Executive Officer | 2021-07-22 | Conversion · Series C Redeemable Preferred Stock | −1,071,428 | 0 | D | ||
| Open-market purchases · 627,500 sh · avg $8.00 · $5,020,000 | |||||||
Loading xslF345X03/doc4.xml…